Mercer Global Advisors
PACB icon

Mercer Global Advisors’s Pacific Biosciences PACB Stock Holding History

Mercer Global Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$87K Buy
51,769
+17,096
+49% +$24.9K ﹤0.01% 3446
2026
Q1 		$45.8K Buy
34,673
+14,010
+68% +$25.1K ﹤0.01% 3130
2025
Q4 		$38.6K Buy
20,663
+6,695
+48% +$12.9K ﹤0.01% 2808
2025
Q3 		$17.9K Buy
13,968
+1,581
+13% +$2.14K ﹤0.01% 2623
2025
Q2 		$15.4K Sell
12,387
-22,507
-65% -$26K ﹤0.01% 2230
2025
Q1 		$41.2K Buy
34,894
+11,068
+46% +$17K ﹤0.01% 2110
2024
Q4 		$43.6K Buy
+23,826
New +$46.5K ﹤0.01% 2090
2020
Q4 		– Sell
-10,165
Closed -$100K – 1383
2020
Q3 		$100K Buy
+10,165
New +$58.5K ﹤0.01% 1177
2020
Q2 		– Sell
-10,165
Closed -$31K – 1132
2020
Q1 		$31K Buy
+10,165
New +$41.6K ﹤0.01% 1069

Other funds holding PACB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Mercer Global Advisors's PACB Position: Q2 2026 in Review

Mercer Global Advisors increased its Pacific Biosciences (PACB) stake by 49% in Q2 2026, buying an estimated $24.9K and bringing the position to 51,769 shares worth $87K. The position accounts for ﹤0.01% of the portfolio, ranked #3446.

Mercer Global Advisors first reported a position in PACB in Q1 2020 and has held it in 9 quarters since. The position peaked at $100K in Q3 2020. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

  • Mercer Global Advisors held 51,769 shares of Pacific Biosciences worth $87K as of Q2 2026.
  • Mercer Global Advisors bought 17,096 Pacific Biosciences shares in Q2 2026, an estimated $24.9K.
  • Pacific Biosciences made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #3446 holding.
  • Mercer Global Advisors first reported a position in Pacific Biosciences in Q1 2020 and has held it in 9 quarters since.
  • Mercer Global Advisors's Pacific Biosciences position peaked at $100K in Q3 2020.
  • 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.